Cue Biopharma News

Oppenheimer: Maintaining the Cue Biopharma (CUE.US) rating, adjusted from superior to superior market ratings, and adjusted the target price from $10.00 to $10.00.

Zhitong FinanceApr 9 20:32

Cue Biopharma Analyst Ratings

BenzingaApr 9 20:20

Oppenheimer Maintains Outperform on Cue Biopharma, Maintains $10 Price Target

BenzingaApr 9 20:22

Oppenheimer Remains a Buy on Cue Biopharma (CUE)

TipRanksApr 9 19:35

Cue Biopharma (CUE) Gets a Buy From Stifel Nicolaus

TipRanksApr 9 19:07

Cue Biopharma Analyst Ratings

BenzingaApr 4 00:00

Piper Sandler Reiterates Overweight on Cue Biopharma, Maintains $8 Price Target

BenzingaApr 4 00:01

Piper Sandler Remains a Buy on Cue Biopharma (CUE)

TipRanksApr 3 19:06

Cue Biopharma Analyst Ratings

BenzingaMar 13 21:00

Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Intellia Therapeutics (NTLA) and Cue Biopharma (CUE)

TipRanksFeb 26 21:10

Cue Biopharma (CUE) Gets a Buy From Piper Sandler

TipRanksFeb 20 20:45

Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), KalVista Pharmaceuticals (KALV) and Cue Biopharma (CUE)

TipRanksNov 14, 2023 03:10

Analysts Conflicted on These Healthcare Names: Cue Biopharma (CUE) and Mirati Therapeutics (MRTX)

TipRanksNov 7, 2023 13:41

Piper Sandler Maintains Overweight on Cue Biopharma, Raises Price Target to $8

BenzingaNov 6, 2023 23:40

Cue Biopharma Analyst Ratings

BenzingaNov 6, 2023 23:40

Analysts Offer Insights on Healthcare Companies: Cue Biopharma (CUE), Zoetis (ZTS) and CymaBay Therapeutics (CBAY)

TipRanksNov 6, 2023 20:51

Cue Biopharma (CUE) Gets a Buy From Piper Sandler

TipRanksAug 10, 2023 21:16

JMP Securities Keeps Their Buy Rating on Cue Biopharma (CUE)

TipRanksAug 10, 2023 12:15

Oppenheimer Assumes Cue Biopharma at Outperform, Announces Price Target of $10

BenzingaJun 26, 2023 18:50

Analysts Conflicted on These Healthcare Names: Cue Biopharma (CUE) and Corvus Pharmaceuticals (CRVS)

TipRanksJun 15, 2023 21:30